AGTHX
Price
$87.77
Change
+$0.48 (+0.55%)
Updated
Sep 11 closing price
Net Assets
353.07B
WPASX
Price
$47.57
Change
+$0.76 (+1.62%)
Updated
Sep 11 closing price
Net Assets
421.64M
Interact to see
Advertisement

AGTHX vs WPASX

AGTHX vs WPASX Comparison Chart in %
View a ticker or compare two or three
VS
AGTHX vs. WPASX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGTHX is a Buy and WPASX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AGTHX has more cash in the bank: 353B vs. WPASX (422M). AGTHX pays higher dividends than WPASX: AGTHX (0.25) vs WPASX (0.00). AGTHX was incepted earlier than WPASX: AGTHX (53 years) vs WPASX (13 years). WPASX (1.00) is less costly to investors than AGTHX (0.59). AGTHX is a more actively managed with annual turnover of: 32.00 vs. WPASX (18.00). AGTHX initial investment is less costly to investors than WPASX (4%) vs WPASX (4%). AGTHX has a lower initial minimum investment than WPASX: AGTHX (250) vs WPASX (2500). AGTHX annual gain was more profitable for investors over the last year : 0.18 vs. WPASX (-15.44). AGTHX return over 5 years is better than : 13.61 vs. WPASX (-23.32).
AGTHXWPASXAGTHX / WPASX
Total Expense Ratio0.591.0059%
Annual Report Gross Expense Ratio0.591.0059%
Fund Existence53 years13 years-
Gain YTD9.085-6.268-145%
Front Load6%4%135%
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets353B422M83,649%
Annual Yield % from dividends0.250.00-
Returns for 1 year0.18-15.44-1%
Returns for 3 years43.29-3.84-1,126%
Returns for 5 years13.61-23.32-58%
Returns for 10 years107.6670.15153%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NAMS22.800.94
+4.30%
NewAmsterdam Pharma Company NV
BYRN3.620.09
+2.55%
Byrna Technologies
CX10.690.03
+0.28%
Cemex SAB de CV
RGNX8.53-0.03
-0.35%
REGENXBIO
CRIS1.13-0.03
-2.59%
Curis Inc.